McGill team wins grant to study 鈥榯rained immunity鈥� with Japanese researchers
Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening McGill鈥檚 relationship with Japan鈥檚 RIKEN institute.
By Junji Nishihata
Reminder: Canada Research Continuity Emergency Fund (CRCEF)
This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.
Kristina 脰hrvall promoted to Assistant Vice-Principal, Research Development
Martha Crago, Vice-Principal, Research and Innovation, announced today that Kristina 脰hrvall has been promoted to Assistant Vice-Principal, Research Development, for a five-year term.
Research and Innovation on a summer schedule, starting June 26
Please note that Research and Innovation (R+I), including all of its associated units, will soon change to a summer schedule as per McGill鈥檚 policy on Summer Fridays.
In practice, this means R+I will function with only minimal staff on Fridays throughout the summer, from June 26 until August 21. R+I will resume regular weekly office hours on Friday, August 28.
Updates on Research Support during the Pandemic
Sent on behalf of Martha Crago, Vice-Principal (Research and Innovation)
听
Dear Colleagues,
I have been thinking of you often, as research is slowly 鈥巗tarting up again at McGill.
Call to McGill Researchers: Complete survey on COVID-19 Diagnostics R&D
The availability of reliable, rapid diagnostics is key to reopening our economies. Canada has an opportunity to take a leadership role in accelerating the development of these tests through a coordinated Canadian response. The goal is to support researchers to build networks and find collaborators/industry partners to advance their ideas to clinical trial and mass production. To that end, Dr.
Help fight COVID-19 by joining the CanCOVID initiative
McGill faculty with relevant expertise are encouraged to join the CanCOVID鈥痠nitiative, an expert community of Canadian COVID-19 researchers, clinical collaborators, and healthcare stakeholders.
McGill spinoff Laurent Pharmaceuticals to begin clinical trial on COVID-19 treatment
Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus
Message to the McGill research community about CFI projects
On March 20, 2020, the Government of Quebec announced an immediate shutdown of constructions sites due to the COVID-19 pandemic. On April 7, it was announced that the date to resume construction activities is听May 4, 2020. This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.听
Guidance Regarding Renewals of Research Staff Contracts
The COVID-19 pandemic and the present need to limit on-campus research has created unprecedented uncertainty for McGill Principal Investigators and the members of your teams. Specifically, many of you have shared your questions and concerns about renewing grant-based employment contracts for your research and laboratory staff 鈥� including postdocs, technicians, research assistants, and research associates 鈥� if their ability to work remains limited in the weeks and months ahead.
A message from Environmental Health and Safety (EHS)
March 30, 2020
Good day everyone,
The staff at Environmental Health and Safety (EHS) would like to take this opportunity to send everyone well wishes during this unprecedented global crisis. We would like to thank you for the sacrifices you have made to help to 鈥渇latten the curve鈥� so that everyone can resume their normal activities, including the very important research that happens at McGill, as soon as possible.
SURVEY - Building a McGill database of research on COVID-19
This message is sent on behalf of Martha Crago, Vice-Principal (Research and Innovation).
听
Dear members of the McGill research community,
Call to all Law and Medical Device Certification Firms: Code Life Ventilator Challenge
The Code Life Ventilator Challenge needs help from compliance and IP experts for expedited review and mentoring of late-stage teams. Expert assistance is needed to ensure that any design can be reviewed and adjusted so as to ensure patient safety, and no IP rights infringement.
Sign up using this simple FORM.
New Program Launch: MI4 funding for COVID-19 research
The McGill Interdisciplinary Initiative in Infection and Immunity (MI4) is pleased to announce the launch of an emergency coronavirus research fund to support nimble and effective interventions and studies in this crisis.
Call to all McGill Labs: Urgent need for reagents for use in COVID-19 testing
The Public Health Agency听of听Canada has an urgent need for reagents for听use in听COVID-19 testing.听听The National Microbiology Lab (NML) is specifically looking for items on the list in the table below, as well as any other 香蕉视频 extraction reagents.